By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Researchers from Columbia University and Brandeis University plan to use a $2 million grant from the National Institute of Neurological Disorders and Stroke to survey and investigate attitudes about taking genetic tests for epilepsy.

The project, led by principal investigator and Columbia University Professor of Epidemiology Ruth Ottman, will involve in-depth interviews and analysis and clinical genetic testing.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.